Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study

Maja Jahnmatz, Laura Richert, Nabil Al‐Tawil, Jann Storsæter, Céline Colin, Claire Bauduin, Marcel Thalen, Ken Solovay, Keith Rubin, Nathalie Mielcarek, Rigmor Thorstensson, Camille Locht, Lena Dager, Nina Ekholm, Margareta Gustafsson, Åsa Linde, Cecilia Lång, M Năstase, Ingalill Reinholdsson, Erla Sigurdardottir, Anneli Wahlberg, Izabella Zarea, Teodora Aktas, Ingrid Andersson, Eva Hanson Pihlainen, Margaretha Ljungman, Maj Ringman, Teghesti Tecleab, Lena Wehlin, Florence Allais, Alex Assuied, Geneviève Chêne, Camille Gilbert, Delphine Jean, Fabien Le Marec, Laëtitia Moinot, Philippe Reboud, Emilie Rousseau, Céline Roy, Christine Schwimmer, Ludivine Taïeb, Cédrick Wallet, Gabrielle Derocle, Sonia Guéguen, Claire Lévy‐Marchal, Hélène Espérou, Anne‐Sophie Debrie, Dominique Raze, Loïc Coutte, Alpha Diallo, Noémie Mercier